Eagle Rare Kentucky Straight Bourbon Whiskey has named Hershel “Woody” Williams of Ona, West Virginia, as the Grand Prize winner of the 2016 Rare Life Award. Eagle Rare will donate $50,000 to Williams’ charity, the Hershel “Woody” Williams Medal of Honor Foundation, and host an awards ceremony in Lexington, Kentucky on February 27, 2016.
The Rare Life Award is an annual recognition program created to honor individuals who exhibit courage, leadership, survival, devotion, character and heroism. Candidates are nominated by friends, family and colleagues. Their stories and photos are posted online at www.eaglerarelife.com.
To view the multimedia release go to:
http://www.multivu.com/players/English/7761951-2016-rare-life-award/
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.
It is estimated that almost 40 percent of men and women in the U.S. will be diagnosed with cancer sometime during their lifetime. Kommah, who was diagnosed at age 29, now has her health and her son, thanks to discoveries made at City of Hope, where scientists and doctors turn laboratory breakthroughs into treatments that defeat cancer.
Today, the nonprofit research and comprehensive cancer center near Los Angeles is rolling out a new initiative that builds on its legacy of discovery to let people know that City of Hope not only offers a uniquely patient-centric, integrated approach to care, but also with the help of donors and volunteers, it is pursuing research that will change the future of medicine.
To view the multimedia release go to:
http://www.multivu.com/players/English/7665051-city-of-hope-miracle-science-soul-campaign/
An international team of researchers led by Gerard D. Schellenberg, PhD, a member of the CurePSP Genetics Consortium and professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania, has identified three new genes that can increase the risk of people developing Progressive Supranuclear Palsy (PSP).
PSP is a rare neurodegenerative brain disease, similar to Parkinson’s disease, which causes severe disability by destroying parts of cells that allow the brain to function normally. While PSP has underlying biological similarities to Alzheimer’s disease, a disease which primarily affects memory, PSP impacts a person’s physical movement and bodily functions. PSP leads to progressive decline in patients — there is no known cause or cure.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/psp/49958/
His talent is rare; his job was well-done: Armand Ferrante, a Whole Foods Market butcher from Middletown, N.J., won the company’s 2012 national Best Butcher competition finale held at Meatopia, the nation’s largest celebration of meat, on Saturday in New York City.
Chef Byres spotlighted the contestants’ original beef cuts with a custom recipe – a Dry Rubbed Best Butcher Steak with Pickled Celery, Mustard Caviar and Buttermilk – that he served up to Meatopia attendees. A recipe for Chef Byres’ BBQ Beef Chile Rub & Coffee Cure is available at www.wholefoodsmarket.com.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55600-whole-foods-market-s-2012-best-butcher-competition
No conversation is more top-of-mind for today’s business and marketing leaders than the impact of social media on the changing face of business in this tough economy.
Simon Mainwaring, author of the New York Times, Wall Street Journal, and Amazon bestseller “We First: How Brands and Consumers use Social Media to Build a Better World”, is at the forefront of this discussion, as he proposes a vision for the re-purposing of the private sector that he characterizes as a shift from “Me-First” to “We-First” capitalism. So timely is his proposal that Amazon named it a Top 10 Business Book for 2011, and strategy+business named it their best Marketing Book of 2011, stating, “We First is that rare marketing book that is truly visionary.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/51616-we-first-social-branding-seminar-simon-mainwaring
A new national survey shows most preteens and teens engage in day-to-day activities that may put them at risk of contracting meningococcal meningitis, a rare, but serious bacterial infection that can cause meningitis and take the life of an otherwise healthy child in just a single day. The National Association of School Nurses (NASN), in collaboration with Sanofi Pasteur, conducted the survey as part of its Voices of Meningitis back-to-school vaccination awareness initiative.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/voicesofmeningitis/50125/
Award winning Director is going to direct three renowned stars of Hollywood. These frames do not need any introduction. This is a very rare combination and definitely be a block buster.
Another Great Video Of The German Artist DJ KopfHoerer Aka Alvin W. M. Van Zweevel. KopfHoerer\'s Awesome Riders On The Storm Cover He Produced For Tube Tech & Udo Niebergall (The Founder Of Cpt. Jack). Right Here 4 You With The Original Video He Made As A Hommage To The Doors. It\'s Rare So Spread The Word. Share As U Like.
The Pharmaceutical Research and Manufacturers of America (PhRMA) today released new advertising as part of its “From Hope to Cures” campaign, highlighting the stories of rare blood and lung cancer survivors.
The newest video in the collection features Matt, who was diagnosed nearly seven years ago with advanced non-small cell lung cancer. When he was diagnosed, he was given a slim chance of living up to five years. However, today Matt continues to lead an active life due to recent advancements in targeted gene therapies and innovations in cancer medicines.
The latest print and digital ads feature Jamie, a vibrant woman diagnosed 15 years ago with chronic myelogenous leukemia (CML). Watching her son grow up was a primary focus for her, and she’s been able to continue to do that and so much more. Thanks to advancements in CML treatments, today she maintains her sense of humor and imparts an infectious joy on those who meet her.
Earlier this year, the first collection of digital and print ads was released featuring Rhys, a five-year-old living with type 1 diabetes and celiac disease. Unveiled alongside the advertising was a video, titled “We’re Fighting Back,” which features both Rhys and Jamie, as well as Jen, a researcher who wakes up every day working to find new treatments and cures for patients.
To view the multimedia release go to:
http://www.multivu.com/players/English/7738431-phrma-from-hope-to-cures/
It is the year 2021 and Kaela is twenty-three years old when her father shares his secret about an extraordinary event that changed his very existence some fifteen years earlier. She was taught many lessons in moral principles growing up, but it’s rare that the most profound of them would be put to the test. A convergence of events gives her father the opportunity to teach her one of the greatest lessons of all.
